Company: CRNX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000950170-25-066982
Chunk: 1

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 outstanding at March 31, 2025 or December 31, 2024

     —

     —

     Common stock and paid-in capital, $0.001 par; 200,000 shares authorized;     93,525 shares issued and outstanding at March 31, 2025;     92,926 shares issued and outstanding at December 31, 2024

     2,300,882

     2,275,952

     Accumulated other comprehensive income

     2,002

     963

     Accumulated deficit

     (1,048,884
     )

     (952,110
     )

     Total stockholders’ equity

     1,254,000

     1,324,805

     Total liabilities and stockholders’ equity
      
     $
     1,361,327

     $
     1,434,592

See the accompanying notes to these unaudited condensed consolidated financial statements.